Qing Su

Shanghai Jiao Tong University (SJTU) - Xinhua Hospital

Shanghai

China

SCHOLARLY PAPERS

3

DOWNLOADS

29

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Efficacy and Safety of the Peroxisome Proliferator-Activated Receptor Pan-Agonist Chiglitazar in Patients with Type 2 Diabetes (CMAP): A 24 Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial

Number of pages: 100 Posted: 21 Aug 2019
Peking University - Department of Endocrinology and Metabolism, Southern Medical University - Chenzhou No.1 People's Hospital, Tangshan Gongren Hospital, Xuzhou Medical University, Harrison International Peace Hospital, Qingdao University - Affiliated Hospital, China Three Gorges University (CTGU) - College of Medical Science, Jilin University (JLU) - Second Hospital, Jiangsu Province Hospital, China Meitan General Hospital, Chongqing University, Chongqing Medical University - Department of Endocrinology, Hebei Medical University, Tianjin Medical University - General Hospital, Government of the People's Republic of China - 306th Hospital, Baogang Hospital of Inner Mongolia, Cangzhou Central Hospital, Fudan University - Zhongshan Hospital, Sichuan University, Government of the People's Republic of China - Fourth Military Medical University, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, Central South University - Department of Endocrinology and Metabolism, Peking University, Central South University - Second Xiangya Hospital, Xiamen University - First Affiliated Hospital, Wuhan University - Zhongnan Hospital, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd and Shanghai Jiao Tong University (SJTU) - Shanghai Diabetes Institute
Downloads 15 (599,366)

Abstract:

Loading...

2.

Predominance of Insulin Resistance Over Beta-Cell Dysfunction as a Diabetes Risk Factor in Chinese Adults: Impact of Obesity in a Nationwide Prospective Study

Number of pages: 36 Posted: 20 Aug 2019
Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Guizhou Medical University (Guiyang Medical University) - First Affiliated Hospital, Fujian Medical University - Fujian Provincial Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, Government of the People's Republic of China - Department of Endocrinology, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Union Hospital, Zhejiang Provincial Center for Disease Control and Prevention - Department of Non-Communicable Disease Control and Prevention, Lanzhou University - Department of Endocrinology, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Tongji Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Sun Yat-Sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhengzhou University - Division of Endocrinology, Southwest Medical University - Affiliated Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Dalian University - Dalian Municipal Central Hospital, Jilin University (JLU) - Department of Endocrinology and Metabolism, Wenzhou Medical University - First Affiliated Hospital, Guangxi Medical University - First Affiliated Hospital, Guangxi Medical University - Department of Endocrine, Shandong University - Qilu Hospital, Nanchang University - Jiangxi Medical School, Harbin Medical University - Second Affiliated Hospital, Zhejiang Provincial Center for Disease Control and Prevention, Central Hospital of Shanghai Jiading District, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Anhui Medical University - Department of Endocrinology, Government of the People's Republic of China - Karamay Municipal People's Hospital, Nanjing Medical University - Nanjing Medical Hospital, Chongqing Medical University - First Affiliated Hospital, Shandong First Medical University - Department of Endocrinology and Metabolism, Johns Hopkins University - School of Medicine, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, University of Texas Health Science Center at San Antonio, Shanghai Jiao Tong University (SJTU) - Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University (SJTU) - Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases and affiliation not provided to SSRN
Downloads 11 (626,951)

Abstract:

Loading...

Diabetes, insulin resistance, beta-cell dysfunction, obesity, nationwide investigation

3.

Adipocyte-Derived Periostin Mediates Glucocorticoid-Induced Hepatosteatosis in Mice

Number of pages: 29 Posted: 07 Sep 2019
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN and Shanghai Jiao Tong University (SJTU) - Xinhua Hospital
Downloads 3 (685,581)

Abstract:

Loading...

glucocorticoid, Periostin, hepatosteatosis, Adipocyte, hyperglycemia, PPARalpha